George Song Portfolio

Invests via Superstring Capital Management LP | Managed by George Song

Invests via Superstring Capital Management LP

Managed by George Song

Automatically Tracked

Tracking: 0 Updated: Yesterday at 09:38 AM

George Song Profile

A seasoned entrepreneur and investor, George Song has made a significant mark in the technology startup landscape. With a career focused on innovative business solutions, he brings deep operational expertise and visionary leadership to emerging companies. His background includes founding successful ventures that leverage cutting-edge technologies, driving substantial growth and market expansion. George’s role as an active investor enables him to nurture budding talent while fostering collaboration across various sectors. With his comprehensive understanding of entrepreneurial dynamics and capital markets, he is well-positioned to identify lucrative opportunities within fast-evolving industries.

Investment Philosophy & Strategy

In a rapidly evolving technology landscape, investment opportunities are abundant for visionary leaders. George Song is well-versed in identifying and cultivating the next wave of innovative startups. His unique approach combines operational know-how with an entrepreneurial mindset, enabling a keen assessment of business models that demonstrate scalability. By fostering synergistic partnerships within the ecosystem, he aims to amplify growth trajectories while optimizing resource allocation. With an emphasis on sectors at the forefront of disruption, his strategy prioritizes agility and market responsiveness as pivotal components for sustainable success.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.

Gain and growth charts are calculated per selected timeframe:

22.21%

Gain +0.02%

Monthly

0.68%

Yearly

8.52%

Drawdown

54.41%

$148.32M

Equity

Holdings

$148.32M

Investment

$129.77M

$39.02M

Profit +$25,805.01

Realized

$20.47M

Unrealized

$18.55M

Dividends

$132,767.92

Goals

Avg. 0% completed goals

Yearly

Gain > 5%

2026

Yearly

Gain < 20%

2026

Today

Compared To Yesterday

Gain

0.02%

Profit

$25,805.01

Win %

58%

This Week

Compared To Last Week

Gain

0.02%

Profit

$25,805.01

Win %

58%

This Month

Compared to last month

Gain

-4.41%

Profit

-$6.84M

Win %

58%

This Year

Compared to last year

Gain

-51.03%

Profit

-$89.79M

Win %

71%

Gainers
Losers

SMMT Summit Therapeutics Inc.

+7.11%

+$830,371.89

ARVN Arvinas Inc.

+6.91%

+$153,183.8

TARA Protara Therapeutics Inc.

+6.85%

+$30,364.25

TNXP Tonix Pharmaceuticals Holding Corp

+6.57%

+$44,478

TVTX Travere Therapeutics Inc.

+6.4%

+$321,620.12

ORIC Oric Pharmaceuticals Inc.

+5.75%

+$51,855.3

TRVI Trevi Therapeutics Inc.

+5.57%

+$188,674.5

CGEM Cullinan Therapeutics, Inc.

+5.55%

+$42,828.48

CLYM Climb Biotherapeutics, Inc.

+4.86%

+$105,580.77

CLDX Celldex Therapeutics Inc.

+4.37%

+$235,862.88

DFTX Definium Therapeutics, Inc.

+2.65%

+$224,935.04

TSHA Taysha Gene Therapies Inc.

+2.33%

+$33,574.97

IMVT Immunovant Inc.

+2.25%

+$264,628.44

ORKA Oruka Therapeutics, Inc.

+2.07%

+$90,299.22

COGT Cogent Biosciences, Inc.

+1.47%

+$108,075.39

ANL Adlai Nortye Ltd. ADR

+1.18%

+$49,782.24

VIR Vir Biotechnology Inc.

+1.06%

+$65,749.32

URGN Urogen Pharma Ltd.

+0.75%

+$85,221.62

AXSM Axsome Therapeutics, Inc.

+0.55%

+$15,703.8

IPSC Century Therapeutics, Inc.

+0.45%

+$1,193.08

PCVX Vaxcyte, Inc.

+0.36%

+$18,777.18

IQV IQVIA Holdings Inc.

+0.22%

+$10,267.51

PFE Pfizer Inc.

+0.15%

+$2,960

UTHR United Therapeutics Corporation

+0.1%

+$2,904.16

CABA Cabaletta Bio Inc.

MPLT MapLight Therapeutics, Inc.

-8.57%

-$499,561.4

ZLAB Zai Lab Ltd.

-3.23%

-$157,216.26

BMEA Biomea Fusion, Inc.

-1.68%

-$5,000

ACRS Aclaris Therapeutics, Inc.

-1.14%

-$18,324.5

DRUG Bright Minds Biosciences Inc.

-1.01%

-$8,252.82

GMAB Genmab A/S Sponsored ADR

-0.63%

-$31,473.44

PTN Palatin Technologies, Inc.

-0.51%

-$2,517.83

SION Sionna Therapeutics Inc.

-0.36%

-$18,332.98

SVRA Savara Inc.

-0.19%

-$15,859.77

VRTX Vertex Pharmaceuticals Incorporated

-0.03%

-$1,211.31

Events

Dividends

Dividend Analysis

No Data

Trades 332	Longs Won 116/332 34%	Profit Factor 1.52
Profitability	Shorts Won 0/0 0%	Standard Deviation $1.48M
Average Win $989,471.06	Best Trade (Mar 30) $15.47M	Sharpe Ratio -48.09
Average Loss -$350,731.78	Worst Trade (Mar 30) -$5.19M	Z-Score -4.04 (100%)
Commissions $0	Avg. Trade Length 5m 3w 6d	Expectancy $117,531.86

Loss Size	100%	90%	80%	70%	60%	50%	40%	30%	20%	10%
Probability of Loss	<0.01%	<0.01%	<0.01%	<0.01%	<0.01%	<0.01%	0.03%	0.34%	2.86%	18.66%
Consecutive Losing Trades	423	381	338	296	254	211	169	127	85	42